Rebecca J. Edge

Liverpool, ENG L35RF, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Virus-like particle display of consensus α-neurotoxins does not enhance neutralising antibody responses against elapid venoms.

Virus-like particle display of consensus α-neurotoxins does not enhance neutralising antibody responses against elapid venoms.

Journal: Vaccine

Published: July 03, 2026

Preclinical evaluation of the neutralising efficacy of three antivenoms against the venoms of the recently taxonomically partitioned E. ocellatus and E. romani.

Preclinical evaluation of the neutralising efficacy of three antivenoms against the venoms of the recently taxonomically partitioned E. ocellatus and E. romani.

Journal: PLoS neglected tropical diseases

Published: February 26, 2025

Nanobody-based recombinant antivenom for cobra, mamba and rinkhals bites.

Nanobody-based recombinant antivenom for cobra, mamba and rinkhals bites.

Journal: Nature

Published: December 16, 2024

De novo designed proteins neutralize lethal snake venom toxins.

De novo designed proteins neutralize lethal snake venom toxins.

Journal: Research square

Published: May 27, 2024

De novo designed proteins neutralize lethal snake venom toxins.

De novo designed proteins neutralize lethal snake venom toxins.

Journal: Nature

Published: May 08, 2024

Plug and play virus-like particles for the generation of anti-toxin antibodies.

Plug and play virus-like particles for the generation of anti-toxin antibodies.

Journal: Toxicon: X

Published: May 08, 2024

African polyvalent antivenom can maintain pharmacological stability and ability to neutralise murine venom lethality for decades post-expiry: evidence for increasing antivenom shelf life to aid in alleviating chronic shortages.

African polyvalent antivenom can maintain pharmacological stability and ability to neutralise murine venom lethality for decades post-expiry: evidence for increasing antivenom shelf life to aid in alleviating chronic shortages.

Journal: BMJ global health

Published: December 11, 2023

ADDovenom: Thermostable Protein-Based ADDomer Nanoparticles as New Therapeutics for Snakebite Envenoming.

ADDovenom: Thermostable Protein-Based ADDomer Nanoparticles as New Therapeutics for Snakebite Envenoming.

Journal: Toxins

Published: October 16, 2023

Two snakebite antivenoms have potential to reduce Eswatini's dependency upon a single, increasingly unavailable product: Results of preclinical efficacy testing.

Two snakebite antivenoms have potential to reduce Eswatini's dependency upon a single, increasingly unavailable product: Results of preclinical efficacy testing.

Journal: PLoS neglected tropical diseases

Published: May 16, 2022

Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms.

Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms.

Journal: Toxins

Published: May 08, 2022

In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus.

In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus.

Journal: Toxicon: X

Published: December 29, 2021

Virus-like particles displaying conserved toxin epitopes stimulate polyspecific, murine antibody responses capable of snake venom recognition.

Virus-like particles displaying conserved toxin epitopes stimulate polyspecific, murine antibody responses capable of snake venom recognition.

Journal: Scientific reports

Published: November 02, 2021

Showing 1-12 of 18

Last Updated: 09/26/2026